Time-dependent influence of infliximab on hemodynamic responses and cardiac injuries of isoproterenol-induced myocardial infarction in rats
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Time-dependent influence of infliximab on hemodynamic responses and cardiac injuries of isoproterenol-induced myocardial infarction in rats
Authors
Keywords
Infliximab, Isoproterenol, Myocardial infarction, Inflammation, Rat
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 903, Issue -, Pages 174122
Publisher
Elsevier BV
Online
2021-04-28
DOI
10.1016/j.ejphar.2021.174122
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges
- (2018) Shuaibo Huang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition
- (2018) Mona Panahi et al. CARDIOVASCULAR RESEARCH
- Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities
- (2018) Sang-Bing Ong et al. PHARMACOLOGY & THERAPEUTICS
- Translational overview of cytokine inhibition in acute myocardial infarction and chronic heart failure
- (2018) Minke H.T. Hartman et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Tumor Necrosis Factor-α in Heart Failure: an Updated Review
- (2018) Sarah M. Schumacher et al. Current Cardiology Reports
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial
- (2016) Ola Kleveland et al. EUROPEAN HEART JOURNAL
- Cardioprotective effect of metformin in lipopolysaccharide-induced sepsis via suppression of toll-like receptor 4 (TLR4) in heart
- (2016) Haleh Vaez et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Treatment with non-steroidal anti-inflammatory drugs in patients after myocardial infarction – a systematic review
- (2016) Lena Boulakh et al. EXPERT OPINION ON PHARMACOTHERAPY
- Anti-Inflammatory Treatment With Colchicine in Acute Myocardial InfarctionClinical Perspective
- (2015) Spyridon Deftereos et al. CIRCULATION
- Anti-inflammatory therapies for atherosclerosis
- (2015) Magnus Bäck et al. Nature Reviews Cardiology
- The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
- (2014) A. C. Morton et al. EUROPEAN HEART JOURNAL
- TNF-Like Weak Inducer of Apoptosis Aggravates Left Ventricular Dysfunction after Myocardial Infarction in Mice
- (2014) Kai-Uwe Jarr et al. MEDIATORS OF INFLAMMATION
- Tacrolimus ameliorates functional disturbances and oxidative stress in isoproterenol-induced myocardial infarction
- (2014) Arash Khorrami et al. DARU-Journal of Pharmaceutical Sciences
- Early short-term doxycycline therapy in patients with acute myocardial infarction and left ventricular dysfunction to prevent the ominous progression to adverse remodelling: the TIPTOP trial
- (2013) G. Cerisano et al. EUROPEAN HEART JOURNAL
- Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study
- (2013) Gareth J Padfield et al. HEART
- Therapeutic Potential of Tumour Necrosis Factor-alpha Antagonists in Patients with Chronic Heart Failure
- (2013) Qamar Javed et al. Heart Lung and Circulation
- Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non–ST-Segment Elevation Myocardial Infarction
- (2013) Jean-Claude Tardif et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- NCDs: a challenge to sustainable human development
- (2013) Helen Clark LANCET
- The Chemokine Decoy Receptor D6 Prevents Excessive Inflammation and Adverse Ventricular Remodeling After Myocardial Infarction
- (2012) Clément Cochain et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Short-term treatment with metformin suppresses toll like receptors (TLRs) activity in isoproterenol-induced myocardial infarction in rat: Are AMPK and TLRs connected?
- (2012) Hamid Soraya et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Plasma levels of tumor necrosis factor-α and interleukin-6 are associated with diastolic heart failure through downregulation of sarcoplasmic reticulum Ca2+ ATPase
- (2011) Cho-Kai Wu et al. CRITICAL CARE MEDICINE
- Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat
- (2011) Alireza Garjani et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Tumor necrosis factor-α produced in cardiomyocytes mediates a predominant myocardial inflammatory response to stretch in early volume overload
- (2010) Yuanwen Chen et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab
- (2008) Hiroki Mitoma et al. ARTHRITIS AND RHEUMATISM
- Simple method for determining human serum 2,2-diphenyl-1-picryl-hydrazyl (DPPH) radical scavenging activity – possible application in clinical studies on dietary antioxidants
- (2008) Jacek Chrzczanowicz et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- TNFα blockade in human diseases: Mechanisms and future directions
- (2007) Maida Wong et al. CLINICAL IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started